The global pharma industry experienced a 21% rise in social media posts on virtual care in Q1 2023 compared with the previous quarter, with the highest share accounted for Bicycle Health, according to GlobalData’s analysis of social media posts. GlobalData’s Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 report provides key insights into business strategies, trends driving the telehealth market and granular data on market segments forecast up to 2030. Buy the report here.
Notably, Covid-19 was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions ahead of orphan designated drugs and innovation, according to GlobalData.
Of the 50 leading companies in the pharma industry, Teva Biopharmaceuticals USA had the most mentions of virtual care in Q1 2023. GlobalData identified 3,410 virtual care-related posts in the industry's social media activity - 0.22% of all posts - and an increase of 21% in Q1 2023 compared with Q4 2022.
For further understanding of GlobalData's Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 buy the report here.
See Also:
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.